Literature DB >> 15655179

Molecular profiling of tumor progression in head and neck cancer.

Thomas J Belbin1, Bhuvanesh Singh, Richard V Smith, Nicholas D Socci, Volkert B Wreesmann, Marta Sanchez-Carbayo, Jessica Masterson, Snehal Patel, Carlos Cordon-Cardo, Michael B Prystowsky, Geoffrey Childs.   

Abstract

OBJECTIVE: To assess gene expression changes associated with tumor progression in patients with squamous cell carcinoma of the oral cavity.
DESIGN: A microarray containing 17 840 complementary DNA clones was used to measure gene expression changes associated with tumor progression in 9 patients with squamous cell carcinoma of the oral cavity. Samples were taken for analysis from the primary tumor, nodal metastasis, and "normal" mucosa from the patients' oral cavity.
SETTING: Tertiary care facility. Patients Nine patients with stage III or stage IV untreated oral cavity squamous cell carcinoma.
RESULTS: Our analysis to categorize genes based on their expression patterns has identified 140 genes that consistently increased in expression during progression from normal tissue to invasive tumor and subsequently to metastatic node (in at least 4 of the 9 cases studied). A similar list of 94 genes has been identified that decreased in expression during tumor progression and metastasis. We validated this gene discovery approach by selecting moesin (a member of the ezrin/radixin/moesin [ERM] family of cytoskeletal proteins) and one of the genes that consistently increased in expression during tumor progression for subsequent immunohistochemical analysis using a head and neck squamous cell carcinoma tissue array.
CONCLUSION: A distinct pattern of gene expression, with progressive up- or down-regulation of expression, is found during the progression from histologically normal tissue to primary carcinoma and to nodal metastasis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15655179     DOI: 10.1001/archotol.131.1.10

Source DB:  PubMed          Journal:  Arch Otolaryngol Head Neck Surg        ISSN: 0886-4470


  31 in total

Review 1.  Molecular predictors of clinical outcome in patients with head and neck squamous cell carcinoma.

Authors:  Giovana R Thomas; Hari Nadiminti; Jacinto Regalado
Journal:  Int J Exp Pathol       Date:  2005-12       Impact factor: 1.925

2.  STAT-Related Profiles Are Associated with Patient Response to Targeted Treatments in Locally Advanced SCCHN.

Authors:  Vassiliki Kotoula; Sofia Lambaki; Despina Televantou; Anna Kalogera-Fountzila; Angelos Nikolaou; Konstantinos Markou; Despina Misailidou; Konstantinos N Syrigos; George Fountzilas
Journal:  Transl Oncol       Date:  2011-02-01       Impact factor: 4.243

3.  Molecular Classification of Lymph Node Metastases Subtypes Predict for Survival in Head and Neck Cancer.

Authors:  Lei Huang; Odile David; Robert J Cabay; Klara Valyi-Nagy; Virgilia Macias; Rong Zhong; Barry Wenig; Lawrence Feldman; Ralph Weichselbaum; Michael T Spiotto
Journal:  Clin Cancer Res       Date:  2018-12-20       Impact factor: 12.531

Review 4.  Emerging role for ERM proteins in cell adhesion and migration.

Authors:  Monique Arpin; Dafne Chirivino; Alexandra Naba; Ingrid Zwaenepoel
Journal:  Cell Adh Migr       Date:  2011-03-01       Impact factor: 3.405

5.  Scientific frontiers: emerging technologies for salivary diagnostics.

Authors:  B J Baum; J R Yates; S Srivastava; D T W Wong; J E Melvin
Journal:  Adv Dent Res       Date:  2011-10

6.  Gene Expression Signatures of Lymph Node Metastasis in Oral Cancer: Molecular Characteristics and Clinical Significances.

Authors:  Xiqiang Liu; Antonia Kolokythas; Jianguang Wang; Hongzhang Huang; Xiaofeng Zhou
Journal:  Curr Cancer Ther Rev       Date:  2010-11-01

7.  Site-specific molecular signatures predict aggressive disease in HNSCC.

Authors:  Thomas J Belbin; Nicolas F Schlecht; Richard V Smith; Leslie R Adrien; Nicole Kawachi; Margaret Brandwein-Gensler; Aviv Bergman; Quan Chen; Geoffrey Childs; Michael B Prystowsky
Journal:  Head Neck Pathol       Date:  2008-08-02

8.  Metal-proteinase ADAM12, kinesin 14 and checkpoint suppressor 1 as new molecular markers of laryngeal carcinoma.

Authors:  Jarosław Markowski; Tomasz Tyszkiewicz; Michał Jarzab; Małgorzata Oczko-Wojciechowska; Tatiana Gierek; Małgorzata Witkowska; Jarosław Paluch; Małgorzata Kowalska; Zbigniew Wygoda; Dariusz Lange; Barbara Jarzab
Journal:  Eur Arch Otorhinolaryngol       Date:  2009-07-16       Impact factor: 2.503

9.  Alterations in myocardial gene expression associated with experimental Trypanosoma cruzi infection.

Authors:  Shankar Mukherjee; Fnu Nagajyothi; Aparna Mukhopadhyay; Fabiana S Machado; Thomas J Belbin; Antonio Campos de Carvalho; Fangxia Guan; Chris Albanese; Linda A Jelicks; Michael P Lisanti; Joao S Silva; David C Spray; Louis M Weiss; Herbert B Tanowitz
Journal:  Genomics       Date:  2008-03-17       Impact factor: 5.736

10.  Clinical relevance of nine transcriptional molecular markers for the diagnosis of head and neck squamous cell carcinoma in tissue and saliva rinse.

Authors:  Benjamin Lallemant; Alexandre Evrard; Christophe Combescure; Heliette Chapuis; Guillaume Chambon; Caroline Raynal; Christophe Reynaud; Omar Sabra; Dominique Joubert; Frédéric Hollande; Jean-Gabriel Lallemant; Serge Lumbroso; Jean-Paul Brouillet
Journal:  BMC Cancer       Date:  2009-10-18       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.